Onclive articles Copyright (c) 2014 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Sun, 29 Mar 2015 09:21:50 UTC 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Thomas Neville's Dynamic Analysis of Multiple PSA Results Leads to Better Reliability, Insights]]>http://www.onclive.com/publications/urologists-in-cancer-care/2015/April-2015/Thomas-Nevilles-Dynamic-Analysis-of-Multiple-PSA-Results-Leads-to-Better-Reliability-InsightsOnclive articlesusSat, 28 Mar 2015 16:00:00 UTCOnclive<![CDATA[mTOR Biology and the Growing Role for mTOR Inhibitors in the Management of Breast Cancer]]>http://www.onclive.com/publications/contemporary-oncology/2015/April-2015/mTOR-Biology-and-the-Growing-Role-for-mTOR-Inhibitors-in-the-Management-of-Breast-CancerOnclive articlesusFri, 27 Mar 2015 17:40:00 UTCOnclive<![CDATA[Advanced Bladder Cancer Increases Suicide Risk, Study Says]]>http://www.onclive.com/publications/urologists-in-cancer-care/2015/April-2015/Advanced-Bladder-Cancer-Increases-Suicide-Risk-Study-SaysOnclive articlesusFri, 27 Mar 2015 13:12:00 UTCOnclive<![CDATA[SGR Repeal Bill Headed for Senate Following House Approval]]>http://www.onclive.com/web-exclusives/SGR-Repeal-Bill-Headed-for-Senate-Following-House-ApprovalOnclive articlesusThu, 26 Mar 2015 20:57:00 UTCOnclive<![CDATA[Role of Chemotherapy in CLL Shifts as Novel Agents Transform Clinical Practice]]>http://www.onclive.com/web-exclusives/Role-of-Chemotherapy-in-CLL-Shifts-as-Novel-Agents-Transform-Clinical-PracticeOnclive articlesusThu, 26 Mar 2015 20:32:00 UTCOnclive<![CDATA[Costly New Drugs Could Lead to Generation of Have-Nots in CLL]]>http://www.onclive.com/web-exclusives/Costly-New-Drugs-Could-Lead-to-Generation-of-Have-Nots-in-CLLOnclive articlesusThu, 26 Mar 2015 12:52:00 UTCOnclive<![CDATA[Frontline Pembrolizumab Bests Ipilimumab in Phase III Melanoma Trial]]>http://www.onclive.com/web-exclusives/Frontline-Pembrolizumab-Bests-Ipilimumab-in-Phase-III-Melanoma-TrialOnclive articlesusWed, 25 Mar 2015 20:43:00 UTCOnclive<![CDATA[Anti-PD-1 Therapy Poised to Take the Next Step in Melanoma]]>http://www.onclive.com/web-exclusives/Anti-PD-1-Therapy-Poised-to-Take-the-Next-Step-in-MelanomaOnclive articlesusWed, 25 Mar 2015 18:11:00 UTCOnclive<![CDATA[Hope Rises for Immunotherapy in Breast Cancer]]>http://www.onclive.com/web-exclusives/Hope-Rises-for-Immunotherapy-in-Breast-CancerOnclive articlesusWed, 25 Mar 2015 14:29:00 UTCOnclive<![CDATA[Dizon Discusses Advantages of IP Chemotherapy for Ovarian Cancer]]>http://www.onclive.com/web-exclusives/Dizon-Discusses-Advantages-of-IP-Chemotherapy-for-Ovarian-CancerOnclive articlesusTue, 24 Mar 2015 21:16:00 UTCOnclive